VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium

Hepatology

Volumn 42, Issue 3, 2005, Pages 549-557

  Chignard, Nicolas ^a,b   Mergey, Martine ^a,b   Barbu, Véronique ^a,b   Finzi, Laetitia ^a,b   Tiret, Emmanuel ^c   Paul, Annick ^a,b   Housset, Chantai ^a,b,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; ALITRETINOIN; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FARNESOID X RECEPTOR AGONIST; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; BILE DUCT; BILE SECRETION; CELL ISOLATION; CELL TYPE; CHOLELITHIASIS; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; GALLBLADDER EPITHELIUM; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELLS, CULTURED; CHENODEOXYCHOLIC ACID; DNA PRIMERS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GALLBLADDER; GENE EXPRESSION REGULATION; HUMANS; ISOXAZOLES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 24144461617     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20806     Document Type: Article

References (46)

1. Meier PJ, Stieger B. Molecular mechanisms in bile formation. News Physiol Sci 2000;15:89-93.
2. Igimi H, Yamamoto F, Lee SP. Gallbladder mucosal function: studies in absorption and secretion in human and in dog gallbladder epithelium. Am J Physiol 1992;263:G69-G74.
3. Baiocchi L, LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte bile secretion. J Hepatol 1999;31:179-191.
4. Cho WK, Boyer JL. Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes. Gastroenterology 1999;117:420-428.
5. Jansson R, Steen G, Svanvik J. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Gastroenterology 1978; 75:47-50.
6. Gunter-Smith PJ, Abdulkadir O, Hammonds-Odie L, Scanlon M, Terrell R. A primary culture of guinea pig gallbladder epithelial cells that is responsive to secretagogues. Am J Physiol Gastrointest Liver Physiol 2000; 279:G866-G874.
7. Usdin TB, Bonner TI, Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994;135:2662-2680.
8. Laburthe M, Breant B, Rouyer-Fessard C. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking: evidence for two classes of binding sites with different structural and functional properties. Eur J Biochem 1984;139:181-187.
9. Pei L. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. J Biol Chem 1996;271:20879-20884.
10. Madsen B, Georg B, Vissing H, Fahrenkrug J. Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. Cancer Res 1998;58:4845-4850.
11. Madsen B, Georg B, Madsen MW, Fahrenkrug J. Estradiol down regulates expression of vasoactive intestinal polypeptide receptor type-1 in breast cancer cell lines. Mol Cell Endocrinol 2001;172:203-211.
12. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;284:1365-1368.
13. Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA, Moore DD. Activation of the orphan receptor RIP14 by retinoids. Proc Natl Acad Sci U S A 1997;94:7909-7914.
14. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-1365.
15. Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001;121:l40-l47.
16. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 2001;276:28857-28865.
17. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6:517-526.
18. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000;6:507-515.
19. Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 2000;43:2971-2974.
20. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis. J Clin Invest 2003;112:1678-1687.
21. Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H, et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 1999;116:179-186.
22. Chignard N, Mergey M, Veissiere D, Pare R, Capeau J, Poupon R, et al. Bile acid transporr and regulating functions in the human biliary epithelium. HEPATOLOGY 2001;33:496-503.
23. Chignard N, Mergey M, Veissiere D, Poupon R, Capeau J, Pare R, et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in the human gallbladder epithelium. Am J Physiol 2003;284:G205-G212.
24. Ballet F, Bouma ME, Wang SR, Amit N, Marais J, Infante R. Isolation, culture and characterization of adult human hepatocytes from surgical liver biopsies. HEPATOLOGY 1984;4:849-854.
25. Kinnman N, Hultcrantz R, Barbu V, Rey C, Wendum D, Poupon R, et al. PDGF-mediated chemoattraction of hepatic srellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000;80:697-707.
26. Housset C, Carayon A, Housset B, Legendre C, Hannoun L, Poupon R. Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest 1993;69:750-755.
27. Mergey M, Lemnaouar M, Veissiere D, Perricaudet M, Gruenert DC, Picard J, et al. CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. Am J Physiol 1995;269:L855-L864.
28. Dray-Charier N, Paul A, Veissiere D, Mergey M, Scoazec JY, Capeau J, et al. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Lab Invest 1995;73:828-836.
29. Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J, et al. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway. J Biol Chem 1995;270:24435-2444l.
30. Xu G, Pan Lx LX, Erickson SK, Forman BM, Shneider BL, Ananthanarayanan M, et al. Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbits. J Lipid Res 2002;43:45-50.
31. Dupont C, Broyart JP, Broer Y, Chenut B, Laburthe M, Rosselin G. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3′,5′-monophosphate in gallbladder epithelial cells of man: comparison with the guinea pig. J Clin Invest 1981;67:742-752.
32. Nyberg B, Einarsson K, Sonnenfeld T. Evidence that vasoactive intestinal peptide induces ductular secretion of bile in humans. Gastroenterology 1989;96:920-924.
33. Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2C1.20. Biochem J 2000;347(Pt 3):623-632.
34. Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, et al. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene: involvement of the farnesoid X receptor/9-cis- retinoic acid receptor heterodimer. J Biol Chem 1999;274:29749-29754.
35. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 2000;275: 10638-10647.
36. Kast HR, Nguyen CM, Sinai CJ, Jones SA, Laffitte BA, Reue K, et al. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 2001;15:1720-1728.
37. Urizar NL, Dowhan DH, Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 2000;275:39313-39317.
38. Chiang JY, Kimmel R, Weinberger C, Stroup D. Farnesoid X receptor responds to bile adds and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Biol Chem 2000;275:10918-10924.
39. Kassam A, Miao B, Young PR, Mukherjee R. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J Biol Chem 2003;278:10028-10032.
40. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543-553.
41. Hwang ST, Urizar NL, Moore DD, Henning SJ. Bile acids regulate the ontogemc expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 2002;122:1483-1492.
42. Kurumiya Y, Nagino M, Nozawa K, Kamiya J, Uesaka K, Sano T, et al. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer. Surgery 2003;133:512-520.
43. Hofmann AF. Bile acids: the good, the bad, and the ugly. News Physiol Sci 1999;14:24-29.
44. Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfaced lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987;28:589-595.
45. Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, et al. Farnesoid X receptor regulates bile acid-amino acid conjugation. J Biol Chem 2003;278:27703-27711.
46. Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004;10: 1352-1358.